Upsher-Smith Laboratories Release: Local Brielle Family Attends 2013 National Walk for Epilepsy® in Washington, D.C.
4/26/2013 9:29:18 AM
More...
|
New Resource for Menopause Has Arrived: Upsher-Smith Laboratories Debuts Redesigned Divigel® Website
4/3/2013 12:35:28 PM
More...
|
Upsher-Smith Laboratories Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile of Once-Daily USL255 (Extended-Release Topiramate)
3/20/2013 9:32:58 AM
More...
|
Upsher-Smith Laboratories Presents Favorable Phase I Data for USL261, a Novel Formulation of Intranasal Midazolam, at 65th Annual Meeting of the American Academy of Neurology
3/19/2013 10:27:03 AM
More...
|
Emerging Data From Upsher-Smith Laboratories's CNS Portfolio Highlighted at 2013 American Academy of Neurology Meeting
3/12/2013 9:25:05 AM
More...
|
Salmon Hormone Sold by Novartis AG (NVS), Upsher-Smith Laboratories and More May Contain Too Much Cancer Risk
3/4/2013 8:22:01 AM
More...
|
Upsher-Smith Laboratories Release: American Heart Month Facts: Dietary Supplement Niacin Has a 20-Year History of Helping to Maintain Good Cholesterol Within a Healthy Range
2/5/2013 10:27:31 AM
More...
|
Auxilium Pharmaceuticals (AUXL) and Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories for Infringement of Testim® Patents
1/29/2013 6:46:00 AM
More...
|
Upsher-Smith Laboratories Release: Epilog.us Hosts Expert Panel Discussion on the Pharmacodynamics of Antiepileptic Drugs (AEDS)
1/14/2013 10:03:53 AM
More...
|
Auxilium Pharmaceuticals (AUXL) and Xstelos Holdings, Inc. Receive 505(b)(2) Paragraph IV Certification Notice From Upsher-Smith Laboratories for Testim®
1/3/2013 8:56:37 AM
More...
|
|